BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Becton, Dickinson and Company (BDX) Announces Award to National Health Service Supply Chain Framework Agreement


12/14/2012 11:56:36 AM

Oxford, UK (December 2012) - BD (Becton, Dickinson and Company), a leading global medical technology company, is proud to accept its successful award to NHS Supply Chain’s National Microbiology Framework Agreement. NHS Supply Chain provides patient-focused healthcare products and supply chain services to the UK’s National Health Service (NHS). The agreement covers a comprehensive product range that sit within the Microbiology department.

Providing customer focussed supply chain services, giving customers a single point of access to thousands of products nationally, BD’s acknowledged award is a step forward in the changing landscape.

The following product areas will be covered via NHS Supply Chain’s Framework Agreement:

• Microbiological Identification Kits: Biochemical, Agglutination Tests

• Manual Antimicrobial Susceptibility Testing

• Pre-Poured Culture Media and Broth

• Automated Blood Culture

• Automated Identification and Susceptibility Analysers

• Automated Identification of Tuberculosis System

• Plate Streakers

• Automated Identification – Maldi TOF (In partnership with Bruker Daltonics)

For further information about BD’s award to NHS Supply Chain’s National Microbiology Framework Agreement, including when products will be available to purchase and how NHS Supply Chain can support your trust set-up specific products for ordering, please visit: www.supplychain.nhs.uk

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES